Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of neutrophil gelatinase-associated lipocalin (NGAL) in colorectal cancer: a meta-analysis.

Genetics and molecular research : GMR - 21 Feb 2014

Wang Y, Zeng T T

Abstract excerpt

Growing evidence has implicated that neutrophil gelatinase-associated lipocalin (NGAL) plays a role in a spectrum of human cancers. Several observational studies from different parts of the world have been devoted to elucidate the clinical relationship between NGAL and colorectal cancer. This meta-analysis aimed to explore the overall accuracy of NGAL detection for the diagnosis and prognosis of colorectal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute-Phase Proteins
Share to Area Under Curve
Share to Lipocalin-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipocalins

Share to Proto-Oncogene Proteins

Share to Publication Bias

Share to ROC Curve

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 24634297
DOI: 10.4238/2014.February.21.11

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of neutrophil gelatinase-associated lipocalin (NGAL) in colorectal cancer: a meta-analysis.PMID 24634297Read ↗

Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer typesSemantic proximity Read ↗

Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner?Semantic proximity Read ↗

Serum neutrophil gelatinase associated lipocalin (NGAL) as a marker of activity in inflammatory bowel diseaseSemantic proximity Read ↗

Genomics and Biological Activity of Neutrophil Gelatinase-Associated Lipocalin in Several Clinical SettingsSemantic proximity Read ↗

Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancerSemantic proximity Read ↗

Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transitionSemantic proximity Read ↗

Lipocalin 2 potentially contributes to tumorigenesis from colitis via IL-6/STAT3/NF-κB signaling pathwaySemantic proximity Read ↗

Upregulated NLGN1 predicts poor survival in colorectal cancerSemantic proximity Read ↗

Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade.Semantic proximity Read ↗

Neutrophil Extracellular Traps Promote a Liver Metastatic Phenotype in Human Colorectal Cancer Cells through Epithelial – Mesenchymal TransitionSemantic proximity Read ↗

Ulcer‐associated cell lineage expresses genes involved in regeneration and is hallmarked by high neutrophil gelatinase‐associated lipocalin (NGAL) levelsSemantic proximity Read ↗

Upregulated NLGN1 predicts poor survival in colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.